相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
Endoplasmic Reticulum Stress-Activated Glycogen Synthase Kinase 3β Aggravates Liver Inflammation and Hepatotoxicity in Mice with Acute Liver Failure
Feng Ren et al.
INFLAMMATION (2015)
Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis
Li Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease
Tae-In Kam et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Models of β-amyloid induced Tau-pathology: the long and folded road to understand the mechanism
Ilie-Cosmin Stancu et al.
MOLECULAR NEURODEGENERATION (2014)
FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease
Tae-In Kam et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Aβ Oligomers through Tau Phosphorylation
Georges Mairet-Coello et al.
NEURON (2013)
Synaptic PI(3,4,5)P3 Is Required for Syntaxin1A Clustering and Neurotransmitter Release
Thang Manh Khuong et al.
NEURON (2013)
Human LilrB2 Is a β-Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model
Taeho Kim et al.
SCIENCE (2013)
Neuropathogenic role of adenylate kinase-1 in A-mediated tau phosphorylation via AMPK and GSK3
Hyejin Park et al.
HUMAN MOLECULAR GENETICS (2012)
Reduction of Synaptojanin 1 Ameliorates Synaptic and Behavioral Impairments in a Mouse Model of Alzheimer's Disease
Laura Beth J. McIntire et al.
JOURNAL OF NEUROSCIENCE (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Tau Protein Is Required for Amyloid β-Induced Impairment of Hippocampal Long-Term Potentiation
Olivia A. Shipton et al.
JOURNAL OF NEUROSCIENCE (2011)
Ablation of Cellular Prion Protein Does Not Ameliorate Abnormal Neural Network Activity or Cognitive Dysfunction in the J20 Line of Human Amyloid Precursor Protein Transgenic Mice
Moustapha Cisse et al.
JOURNAL OF NEUROSCIENCE (2011)
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
Moustapha Cisse et al.
NATURE (2011)
SHIP2 and its involvement in various diseases
Akira Suwa et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
The inositol 5-phosphatase SHIP2 regulates endocytic clathrin-coated pit dynamics
Fubito Nakatsu et al.
JOURNAL OF CELL BIOLOGY (2010)
Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
David A. Gimbel et al.
JOURNAL OF NEUROSCIENCE (2010)
The Inositol Phosphatase SHIP2 Negatively Regulates Insulin/IGF-I Actions Implicated in Neuroprotection and Memory Function in Mouse Brain
Yoshiyuki Soeda et al.
MOLECULAR ENDOCRINOLOGY (2010)
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
Junko Sasaki et al.
NATURE (2010)
Involvement of Fc Receptors in Disorders of the Central Nervous System
Eitan Okun et al.
NEUROMOLECULAR MEDICINE (2010)
Fcγ RECEPTORS CONTRIBUTE TO PYRAMIDAL CELL DEATH IN THE MOUSE HIPPOCAMPUS FOLLOWING LOCAL KAINIC ACID INJECTION
S. Suemitsu et al.
NEUROSCIENCE (2010)
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Claudia Balducci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Phosphoinositide signalling in cancer: beyond PI3K and PTEN
Tom D. Bunney et al.
NATURE REVIEWS CANCER (2010)
Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2
A. Suwa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
Regulation of phosphoinositide 3-kinase expression in health and disease
Klaartje Kok et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice
Dick Terwel et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model
Chiho Hirata-Fukae et al.
BRAIN RESEARCH (2008)
Impact of transgenic overexpression of SH2-containing inositol 5′-phosphatase 2 on glucose metabolism and insulin signaling in mice
Syota Kagawa et al.
ENDOCRINOLOGY (2008)
Blocking Aβ42 Accumulation Delays the Onset and Progression of Tau Pathology via the C Terminus of Heat Shock Protein70-Interacting Protein: A Mechanistic Link between Aβ and Tau Pathology
Salvatore Oddo et al.
JOURNAL OF NEUROSCIENCE (2008)
A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function
John D. Cahoy et al.
JOURNAL OF NEUROSCIENCE (2008)
Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism
Diego E. Berman et al.
NATURE NEUROSCIENCE (2008)
Membrane recognition by phospholipid-binding domains
Mark A. Lemmon
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Lipid signalling in disease
Matthias P. Wymann et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Intracellular amyloid-β in Alzheimer's disease
Frank M. LaFerla et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Regulation of phosphoinositide 3-kinase signaling by oxidants: Hydrogen peroxide selectively enhances immunoreceptor-induced recruitment of phosphatidylinositol(3,4) bisphosphate-binding PH domain proteins
Samuel M. S. Cheung et al.
CELLULAR SIGNALLING (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The metabolic syndrome and Alzheimer disease
George Razay et al.
ARCHIVES OF NEUROLOGY (2007)
Use of the GRP1 PH domain as a tool to measure the relative levels of PtdIns(3,4,5)P-3 through a protein-lipid overlay approach
Herve Guillou et al.
JOURNAL OF LIPID RESEARCH (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Phosphoinositides in cell regulation and membrane dynamics
Gilbert Di Paolo et al.
NATURE (2006)
Association of metabolic syndrome with Alzheimer disease : A population-based study
M. Vanhanen et al.
NEUROLOGY (2006)
The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation
Florian Plattner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules
Xue Zhang et al.
FASEB JOURNAL (2006)
PTEN, a negative regulator of P13 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3
Fiona Kerr et al.
FEBS LETTERS (2006)
Antibodies against β-amyloid reduce Aβ oligomers, glycogen synthase kinase-3β activation and τ phosphorylation in vivo and in vitro
QL Ma et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
Regulation of NMDA receptor trafficking by amyloid-β
EM Snyder et al.
NATURE NEUROSCIENCE (2005)
Impact of Src homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling
S Kagawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity
MW Sleeman et al.
NATURE MEDICINE (2005)
Longer forms of amyloid β protein:: Implications for the mechanism of intramembrane cleavage by γ-secretase
Y Qi-Takahara et al.
JOURNAL OF NEUROSCIENCE (2005)
Natural oligomers of the amyloid-protein specifically disrupt cognitive function
JP Cleary et al.
NATURE NEUROSCIENCE (2005)
ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease
JW Lustbader et al.
SCIENCE (2004)
Deciphering the molecular basis of memory failure in Alzheimer's disease
DM Walsh et al.
NEURON (2004)
Pathways towards and away from Alzheimer's disease
MP Mattson
NATURE (2004)
Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
S Oddo et al.
NEURON (2004)
SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling
YJ Wang et al.
JOURNAL OF IMMUNOLOGY (2004)
Polymorphisms in type IISH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome
PJ Kaisaki et al.
DIABETES (2004)
α7 nicotinic acetylcholine receptors mediate β-amyloid peptide-induced tau protein phosphorylation
HY Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β
M Hoshi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts
A Gray et al.
ANALYTICAL BIOCHEMISTRY (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Tau is essential to β-amyloid-induced neurotoxicity
M Rapoport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin
JM Dyson et al.
JOURNAL OF CELL BIOLOGY (2001)
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
J Lewis et al.
SCIENCE (2001)
Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity
T Wada et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Intracellular delivery of phosphoinositides and inositol phosphates using polyamine carriers
S Ozaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of FcγRIIB in B cells under negative signaling
E Muraille et al.
IMMUNOLOGY LETTERS (2000)
β-amyloid1-42 binds to α7 nicotinic acetylcholine receptor with high affinity -: Implications for Alzheimer's disease pathology
HY Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
